The NHS doesn’t offer bowel screening until we’re 50. Yet with cancer rates rising, it may be worth forking out for a private ...

The interventional oncology market valued at US$ 2.53 Billion in 2023, is forecasted to grow at a robust CAGR of 9.0%, reaching US$ ...

The interventional oncology market valued at US$ 2.53 Billion in 2023, is forecasted to grow at a robust CAGR of 9.0%, reaching US$ 2.75 Billion in 2024 and an impressive US$ 4.24 Billion by 2029. The ...

Aspirin use in patients with PI3K-mutated colorectal cancer helped to reduce disease recurrence, highlighting the importance ...

Three-year results from the ALASCCA trial (NCT02647099), presented at the 2025 ASCO Gastrointestinal Cancer Symposium, showed ...

Cancer is a leading cause of mortality worldwide, and men above 40 are particularly at risk for certain types. While several ...

[66] Acute amoebic colitis ranges from mild to severe, and can be fulminant, leading to colon perforation ... in the treatment of luminal forms of the parasite. [68] Intestinal Infection.

Aspirin did not provide any clinical benefits in a cohort of patients with colorectal cancer who had no history of cardiovascular disease or stroke.

Cancer mortality has increased in the last decade, with 8,140 cases compared to 6,278 in 2014. The report 'The figures of ...

Recent trends reveal a sharp rise in cancer cases in India, with younger patients and a lack of effective screening programs ...

Can pollution cause it? What about inflammation? And how do tumors spread? Here’s what scientists are learning about this ...